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tion and drive regeneration to functional maturity is significant (5) . Essential to muscle regeneration are satellite cells residing beneath the basal lamina of each myofiber. After injury, quiescent satellite cells are activated to form a proliferative pool of myoblasts that differentiate and fuse to provide myonuclei for repair or replacement of damaged myofibers (12) .
Once myotubes reach functional maturity, they express and maintain nicotinic ACh receptors (nAChRs), which mediate muscle contraction through ligand-binding voltage-gated Na ϩ channels. Plasticity of nAChRs clustered at the motor end plate, in the context of size, shape, and density, is crucial for muscle homeostasis and function (16, 48) . For example, synaptic transmission progressively weakens with advanced aging, and its dysfunction is a major pathological feature of neurodegenerative diseases such as amyotrophic lateral sclerosis (47) . However, physical activity can increase the functional plasticity of neuromuscular junctions and may improve motor function for athletes and patients undergoing physical rehabilitation (17, 26) . Myoblast differentiation and synthesis of proteins regulating functional outcomes are dependent on multiple inputs from cytokines and growth factors, including IGF-I, hepatocyte growth factor, IL-6, TNF␣, myostatin, and others derived from the cellular milieu (9) . Thus strategies aimed at promoting the functional regeneration of muscle, such as through endogenous cells within the body that supply the cellular milieu with these mediators, are timely for many demographics (46) .
Fibroblasts comprise Ͼ50% of the extramuscular cell populations within skeletal muscle (22) and are a major cellular component of regenerating muscle, ensuring effective and efficient repair (37) . Fibroblasts also synthesize a unifying connective tissue designed to meet the biophysical demands of a dynamically functioning muscle and can respond to mechanical stimuli within minutes (49) . Thus fibroblasts serve as sensitive mechanotransducers by modifying expression of extracellular matrix proteins and secreting cytokines that have documented effects on nearby muscle (46) . We and others have also shown that different versions of biomechanical strain can uniquely influence behavior of fibroblasts and their resulting secretions (7, 36) ; therefore, strain may serve as a vehicle to direct fibroblast-mediated muscle repair. Supporting evidence shows that regimental stretching can reorganize fibroblast-rich connective tissue and induce muscle hypertrophy (14) , which has lasting synergistic effects on strength gains and muscle activation (32) . However, fibroblasts also synthesize fibrotic and inflammatory molecules, which are pathogenic to skeletal muscle (18, 44) , and repetitive tasks that result in excessive use of skeletal muscle and its surrounding muscle fascia can result in fibroblast-mediated inflammation, strain-induced injury, and dystonia (29) . Understanding the mechanisms by which biomechanical strain influences the bipotent roles of fibroblasts is a major step in shifting fibroblasts toward a phenotype preferential to the functional regeneration of skeletal muscle.
Our laboratory has developed methods to mechanically strained fibroblasts seeded on flexible membranes (35) . With a clinically relevant stretch treatment as a reference, we developed an acyclic long-duration strain (ALDS) regimen after myofascial release, a form of manipulative treatment that applies sustained force to fibroblast-rich tissues to release restriction points (41) . By analyzing video recordings of clinicians manually performing myofascial release, we determined the strain magnitude and duration required to develop an in vitro model. We have shown that a single ALDS treatment has significant effects on fibroblast secretions, including angiogenin, granulocyte colony-stimulating factor, thymus and activation-regulated chemokine, IL-1␤, IL-3, and IL-8 (7) . We also developed a cyclic short-duration strain (CSDS) regimen to induce a stress injury response in the fibroblasts and a combined strain regimen (CSDS ϩ ALDS) to model a repetitive strain injury followed by a manipulative treatment, as might typically be experienced clinically. We have shown that 1 min of ALDS can reverse CSDS-induced disorganization of fibroblast actin architecture and proximally decreases lamellipodia as to change fibroblast morphology from an elongated to a stellate shape (35) .
Using these models, we built a fibroblast-skeletal muscle coculture and demonstrated that strain-activated fibroblasts significantly enhance myoblast differentiation through IL-6 (27) . The current study extends our previous work by investigating the functional phenotype of myotubes differentiated in the presence of strain-activated fibroblasts. We hypothesized that fibroblasts subjected to specific variations of strain magnitude, duration, and frequency could modify the differentiation or development of nearby myotubes and use contractility and nAChR expression and organization as differentiation markers. We also hypothesized that CSDStreated fibroblasts would induce an injury-like myotube phenotype relative to nonstrained fibroblasts and that ALDS applied after CSDS would recover CSDS-mediated effects. We developed a novel method to investigate in vitro myotube contraction in response to incremental doses of ACh. While others used electric pulse stimulation to quantify skeletal myotube contraction in vitro (33), our approach allowed for a more direct correlation to nAChR expression and clustering in myotube populations. We also used quantitative fluorescence imaging to measure nAChR clusters based on previous studies (1, 25) and show that strained and nonstrained fibroblasts are capable of regulating the phenotypic outcomes of myotubes. Thus fibroblasts may serve as a novel target for strategies aimed at facilitating the functional regeneration of skeletal muscle. (Fig. 1A) . Cell cultures were kept at 5% CO 2 and 37°C in all experiments. Differentiation medium (DM, 2% horse serum; ATCC) was used as a positive control to verify that lot-specific myoblasts were capable of differentiation. In no instance were myotubes from DM and FBS media statistically compared, as differences in sera, seeding densities, and culture time may have confounded the analyses. DMEM (catalog no. 11885076, Life Technologies) served as a basal medium for FBS and horse serum.
METHODS

Coculture
After 24 h, coverslips containing myoblasts were transferred to Bioflex wells containing fibroblasts and oriented such that the myoblasts faced the fibroblasts. The coverslip and Bioflex membrane dimensions allowed for 5.2-cm 2 of gas exchange per 9.6-cm 2 surface area. Immediately after the coculture was established, fresh growth medium (2% FBS in DMEM) was added, and strain regimens were initiated. The FX-4000 Tension Plus System (Flexcell International) is a computer-controlled device designed to deliver negative-pressure vacuum through user programming of strain magnitude, duration, and frequency. Bioflex membranes were strained equiradially using four protocols, as described previously (27, 35) . 1) For the nonstrain protocol, fibroblasts were grown on Bioflex membranes but were not subjected to strain. 2) For the ALDS protocol, fibroblasts grown on Bioflex membranes were subjected to a single acyclic strain. Membranes were elongated 3%/s until they were 6% beyond resting length. Strain was held for 60 s and returned to baseline at 1.5%/s. 3) For the CSDS protocol, fibroblasts grown on Bioflex membranes were cyclically strained at 0.6 Hz for 8 h. Membranes were elongated 33%/s until they were 10% beyond resting length and then immediately returned to baseline at 33%/s. There was a 1-s rest phase between the end of one cycle and the beginning of the next cycle. 4) For the CSDS ϩ ALDS protocol, fibroblasts on Bioflex membranes were subjected to CSDS, allowed to rest for 3 h, and then subjected to ALDS.
After strain regimens, cells remained in cocultures without medium change for 96 h to allow secreted mediators from strain-activated fibroblasts to induce myotube differentiation, as we previously reported (27) . Coverslips containing differentiated myotubes were then assessed for myotube differentiation parameters and resulting functional phenotypes (see below).
Measurements of strain-induced fluid forces on myoblast viability and myotube differentiation in the presence and absence of fibroblasts. To test whether myotubes exposed to the strain environment were affected by fluid forces and media agitation, C2C12 cells in non-fibroblast-stretch experiments were analyzed for proliferation, differentiation, and viability at 3, 48, and 96 h poststrain (Fig. 1) . Myoblast proliferation was measured by counting DAPI-labeled nuclei per millimeter squared, myotube differentiation was measured by counting cells expressing myosin with at least three nuclei, and fusion index was calculated as the percentage of nuclei in myotubes relative to the entire C2C12 cell population. C2C12 cells are highly metabolically active, and because 96 h without medium change could potentially impact cell viability, extracellular DNA produced as a result of cell death was assayed from conditioned medium (catalog no. G8742, Promega). Manufacturer-recommended culture conditions for C2C12 cells that include a medium change every 24 h and a starting cell density of 13.3 ϫ 10 4 cells/ml in 10% FBS were used for comparison. Data are presented in raw fluorescence units per culture well. Trypan blue exclusion was also performed for all time points and treatments. While we previously analyzed myotube differentiation from all strain treatments in 21 separate cell cultures (27) , in this set of experiments we exposed C2C12 cells in uniculture and coculture to only the CSDS and nonstrain paradigms to extend our previous work on the effects of non-fibroblast-stretch experiments. We included a 3-h post-CSDS time point, when ALDS would typically be applied in the CSDS ϩ ALDS paradigm, and a 48-h time point, half-way through the experiments, to measure earlier effects on myoblast proliferation and cell viability. To establish proof of concept for early myogenic activation by fibroblasts and strain, we also measured myogenin and MyoD (catalog nos. QT00112378 and QT00101983, Qiagen) by pooling mRNA from two culture wells per treatment (1 g) and analyzing by real-time PCR, with expression of each gene normalized to that of GAPDH using the threshold cycle (⌬⌬C T) method (catalog no. QT01658692, Qiagen). Six independent samples were analyzed (n ϭ 6, see Statistics).
Myotube contraction studies. Next, we were interested in determining whether the myotubes differentiated in the presence of strained and nonstrained fibroblasts were functionally different from one another. Thus a perfusion system was devised to induce in vitro myotube contraction and test the functional capacity of cocultured myotubes. Coverslips containing myotubes were removed from co- Fig. 1 . Effects of fibroblasts and mechanical strain on myoblast differentiation. A and B: myoblasts on nondeformable coverslips were situated 2 mm above deformable Bioflex membranes containing fibroblasts. C-N: myoblasts in nonstrain uniculture, nonstrain coculture, cyclic short-duration strain (CSDS) uniculture, and CSDS coculture were fluorescently labeled for actin (red), myosin (green), and nuclei (blue) at 3, 48, and 96 h poststrain. O-Q: myoblast proliferation, myotube differentiation, and fusion efficiency. *P Ͻ 0.05 vs. uniculture. R: cytotoxicity measured in raw fluorescence units per well from mechanical strain, coculture, and 96 h without medium change compared with manufacturer's recommended culture conditions. ␥P Ͻ 0.05 vs. manufacturer conditions. cultures and outfitted in 35-mm perfusion plates with attached inflow and outflow tubing holders. The apparatus allowed for continuous superfusion of myotubes with various contractile agonists and wash buffers. The velocity of perfusate was controlled by two variable-flow peristaltic pumps (model 138761, Fisher Scientific), and the perfusate was delivered through 1/16-in. tubing at 4.2 cm/s. The outflow tubing was situated 3 mm above the inflow tubing to ensure constant submersion of myotubes with perfusate. Perfusion plates were positioned on the stage of an IX71 Olympus inverted microscope that monitored perfusions by video microscopy, capturing 29 frames per second. High-powered fields (HPFs) with at least three myotubes were randomly selected for perfusion to account for fields of view containing no myotubes, as typically found in uniculture (Fig. 1E ). Myotubes were defined as syncytial cells with at least three nuclei (27) .
Myotubes were sequentially perfused for 1 min with log 10 increments of ACh (10 Ϫ11 -10 Ϫ4 M). Myotubes were washed with 1ϫ PBS for 1 min between perfusions to remove previously perfused ACh. All perfusates were isosmotic and kept at 37°C, pH 7.4, to negate the effects of osmolality, temperature, and pH on myotube contraction. The perfusion plate was placed on a transparent 37°C thermoplate stage-top incubator (model MATS-U55R30, Tokai Hit) during video capture for additional temperature control.
To separate medium-and perfusion-related changes from AChspecific effects relating to progressive decreases in myotube area, we performed additional experiments in which myotubes differentiated in the presence of nonstrained fibroblasts were perfused with one of four perfusates. Perfusate groups included PBS only, PBS containing ACh (10 Ϫ11 -10 Ϫ3 M), PBS containing ACh (10 Ϫ11 -10 Ϫ3 M) and 1.8 mM Ca 2ϩ , and PBS containing ACh (10 Ϫ11 -10 Ϫ3 M) perfused in myotubes treated with unconjugated ␣-bungarotoxin (␣-BGT; catalog no. ab120542, Abcam). Myotubes treated with ␣-BGT were immediately transferred to our perfusion apparatus, and ACh was administered (see Fig. 3B ). A final dose of KCl (10 Ϫ2 M) was added to all treatments to depolarize the myotube sarcolemma independently of nAChR activation.
Sequential videos of ACh-and KCl-induced myotube contractions were analyzed with Adobe Premiere Pro 5.0. The last still frame from each perfusion video was extracted, and images were input into ImageJ for analyses. For length-shortening experiments, 10 random coordinate points were identified on each myotube and measured using ImageJ. Alternatively, sarcolemma perimeters (Fig. 2B , shown in phase-contrast mode) were carefully outlined and computationally filled to produce binary images representative of myotube areas on a blank canvas. To avoid potential bias, all fully visible myotubes per field, except those that overlapped each other in a manner that could potentially influence contraction, were outlined. Binary images of outlined myotubes were then exported to ImageJ, and myotube areas were measured. All myotubes per HPF video were analyzed as percent contraction relative to their own precontractile area. ACh-induced myotube contraction is reported as the percentage of fractional shortening relative to a precontractile value of 100%. Maximum fractional shortening in response to ACh, half-maximum (50%) effective dose (ED50), and Hill slope, a measure describing the fraction of nAChRs bound by ACh (40), were calculated (see Statistics). The R 2 value quantifies Hill slope goodness of fit. The minimal fractional shortening required to cause statistically significant contraction from a precontractile value of 100% was also determined. Myotube contraction values from each HPF were averaged from one video per HPF (n ϭ 1). A total of 12 perfusion videos (corresponding to 105-140 myotubes) were independently captured for each treatment (n ϭ 12).
Quantification of AChRs by Western blotting. To measure nAChR expression, myotubes were removed from coverslips using a cell scraper and lysis buffer (catalog no. P8340, Sigma). Three coverslips per treatment were pooled to acquire sufficient protein (50 g/lane). Proteins were separated on 4 -20% Tris·HCl gels in a Mini-Protean II electrophoresis cell (Bio-Rad). Samples were transferred to nitrocellulose membranes and probed for AChR (57 kDa; catalog no. sc-14000, Santa Cruz Biotechnology). Fluorescent secondary antibodies (catalog no. 926-32211, LI-COR) were used to label AChR at a wavelength of 800 nm and the molecular weight ladder (catalog no. 928-40000, LI-COR) at 700 nm. Membranes were stripped using 0.2 M NaOH for 1 min. They were washed five times with PBS and reprobed for GAPDH (33 kDa; catalog no. sc-25778, Santa Cruz Biotechnology). Protein expression from Western blotting was calculated using relative quantification from fluorescence densitometry data generated by LI-COR Odyssey software. Myoblasts in uniculture, seeded on coverslips and transferred to Bioflex wells devoid of fibroblasts (2% FBS), served as a negative control. Treatment results are expressed as fold change from uniculture and normalized to endogenous control GAPDH. Seven independent samples (21 pooled wells) were analyzed per treatment (n ϭ 7).
Identification of AChR clusters for quantitative analyses. AChRs present on differentiated myotubes were fluorescently labeled with tetramethylrhodamine-␣-BGT (catalog no. T1175, Molecular Probes), and quantitative fluorescence imaging was performed using an opensource software package in CellProfiler (Broad Institute). The automated image cytometry system identifies and measures objects' size, shape, pixel intensity, and topology, and resulting acquired data are contrasted against a background-subtraction algorithm (8) . Settings to identify nAChR clusters in CellProfiler were established using agrintreated myotubes (16 h, 1 g/ml recombinant rat agrin; catalog no. 550-AG100, R & D Systems) grown in DM. Agrin, normally secreted by motor neurons, stabilizes and aggregates nAChRs into distinguishable cluster regions (Ն65% intensity), whereas outside these regions, nAChRs largely exist in dispersed microclusters (Ͻ65% intensity) denoted by lower-intensity pixels, as described by others (1, 19) . Myotubes from coculture experiments were incubated with 1 g/ml ␣-BGT for 30 min; then coverslips containing myotubes were removed from coculture, fixed with 2% formaldehyde, and mounted on prelabeled microscope slides in DAPI-VECTASHIELD (catalog no. H1200, Sigma). Treatment identification labels were concealed and coded, and slides were imaged by a blinded observer. Microscope settings for intensity, exposure time, and staining techniques were stringently controlled to maintain fluorescence consistency over the months ␣-BGT experiments were conducted. As a gain control, a HPF devoid of myotubes was selected, and gain settings were decreased until the HPF was completely black. Then 6 -16 images were randomly obtained at ϫ20 magnification (0.58 mm 2 /HPF) for each independent cell culture. To further account for variations in fluorescence intensity, data were analyzed using two-factor ANOVA, with the date of staining and treatment group as independent variables. Twelve randomly and blindly selected myotubes from each independent cell culture were analyzed by CellProfiler. In this manner, nAChR area measurements were obtained for individual myotubes (108 myotubes/treatment, n ϭ 9). To further investigate if strainactivated fibroblasts remodeled ␣-BGT-stained regions, a histogram that quantified the size distribution of AChR clusters, 4 -1,024 m 2 , was created.
Statistical analysis. Data were analyzed using one-factor ANOVA with post hoc Tukey's tests and P Ͻ 0.05 to test significance, unless specifically stated. For cytotoxicity studies, post hoc Dunnett's test was used to compare treatment groups with the manufacturer-recommended culture conditions (P Ͻ 0.05). For contraction studies, ACh concentrations were converted to log10, and a four-parameter logistics sigmoid-shaped dose-response curve with variable slope was used to determine log(ED50) and Hill slope for each treatment. A precontractile value of 100% was assigned to all groups, and a one-sample t-test with null hypothesis that the mean is equal to 100% was used to determine the threshold concentration of ACh that caused a difference from precontraction. For nAChR cluster distribution studies, we logarithmically transformed our histogram to reflect a distribution where the y-axis vs. the logarithm of the x-axis was normal (or Gaussian) in nature as surface area of the receptors (m 2 ) increased logarithmically. The geometric mean was used to calculate the aver-age AChR cluster size of the lognormal distribution. Data between experiments were then correlated by plotting the combined means Ϯ SE derived from each experimental procedure and each treatment group. Linear regression analysis was used to calculate R 2 . Student's t-tests were used to compare differences between agrin-treated and untreated myotubes grown in DM (P Ͻ 0.05). All figures were made using GraphPad PRISM 5.0.
RESULTS
Fibroblasts enhance myoblast differentiation in coculture.
We have developed a novel fibroblast-skeletal muscle coculture to allow myoblast differentiation in the immediate vicinity of strained fibroblasts that does not require replacement of fibroblast-conditioned medium. At no point did coculture result in increased cytotoxicity. Although cell number in coculture was more than double that in uniculture, cytotoxicity was reduced, suggesting that fibroblasts and their secretions increase the vitality of nearby myoblasts. Strain-dependent trends exerted a 6.0 -9.1% increase in cytotoxicity vs. nonstrain, which resulted in significance between ATCC-recommended culturing conditions and CSDS applied to empty Bioflex wells (P Ͻ 0.05; Fig. 1R ). Myoblast differentiation was not measured until 96 h poststrain, perhaps due to the low seeding density and reduced FBS concentration in our system. Importantly, however, at 96 h fibroblasts significantly increased myoblast differentiation and fusion index vs. uniculture (P Ͻ 0.05; Fig. 1, P and Q) . Application of CSDS did not significantly affect myoblast differentiation vs. nonstrain, but strain-dependent trends show decreased myoblast fusion. Myoblast proliferation was also not found to be different across treatment groups (Fig. 1O) . However, at 3 and 48 h poststrain, the density of myoblasts per square millimeter varied within a single coverslip, resulting in large 95% confidence intervals (data not shown). In a separate study, we pooled two independent cultures from each treatment and measured myogenin and MyoD. Myogenin expression increased in nonstrain coculture by 8.8-fold and in CSDS coculture by 13.3-fold vs. uniculture at 24 h poststrain (P Ͻ 0.05; data not shown). However, we did not measure a change in MyoD, perhaps because it is also expressed by proliferating myoblasts. In combination with our laboratory's previous findings (27) , these data served as a basis for investigating the functional phenotype of myotubes differentiated in the presence of strained fibroblasts.
Length measurements of intracellular myotube organelles show a contraction-relaxation-like response to ACh. Myotube length measurements identified shortening of intracellular structures in response to low doses of ACh that returned to original resting length during PBS wash, suggesting that contraction-relaxation occurred in myotubes (Fig. 2A) . However, other coordinates on the same the myotube did not change position. Thus measurements of myotube length produced variable results, depending on the placement of the line segment, making it impossible to reproducibly measure changes between myotubes.
Because of the variability in ACh-induced length shortening, the total area of the myotube was measured (Fig. 2B) . However, the contraction-relaxation of intracellular structures identified by line segment shortening could not be ascertained when changes in myotube area were measured. Therefore, AChinduced loss of cell adhesion was used as a surrogate for myotube contraction. Importantly, we show that increased doses of ACh resulted in progressive decreases in myotube area consistently measurable across all treatment groups.
Strain-activated fibroblasts regulate in vitro myotube contraction independent of fibroblast-regulated myotube hypertrophy. We have developed a universally available system for examining in vitro myotube contraction. Myotubes from coculture experiments contracted from original resting area in response to 10 Ϫ10 M ACh, and followed a sigmoid-shaped doseresponse curve when perfused with increasing concentrations of ACh (10 Ϫ11 -10 Ϫ3 M). The maximum ACh-induced fractional shortening was 70 -80% of original resting length across all myotube treatments (Fig. 3C) . Coculture myotubes shortened 9.0 -10.7% more than uniculture myotubes (P Ͻ 0.05). However, maximum shortening did not vary among coculture treatments. ED 50 values for myotubes grown in coculture averaged 1-6 ϫ 10 Ϫ9 M ACh. Of these myotubes, those differentiated in the presence of CSDS-treated fibroblasts decreased the ACh concentration needed to reach ED 50 by 15-fold vs. uniculture myotubes. The Hill slope coefficient, another index of ACh ligand binding and contractile potency, produced a similar result. The Hill slope goodness of fit (R 2 ) was 0.74 -0.87. The average number of myotubes analyzed per HPF was 6.3-10.0 per treatment ( Fig. 4B ; P Ͼ 0.05), indicating that the densities of myotubes were similar across treatments and likely were not a factor driving ACh sensitivity changes.
In the process of calculating myotube contraction, the precise tracings of their outlines generated extensive data about myotube size. Thus we extrapolated how myotubes responded to fibroblasts in the context of hypertrophic growth. Myotube surface areas were 1,100 -47,000 m 2 . The average myotube surface area per treatment was 3,500 -5,800 m 2 (Fig. 4) . Coculture increased average myotube area by 50.9% vs. uniculture (P Ͻ 0.05), and of the cocultures subjected to strain, CSDS-treated fibroblasts increased myotube area an additional 18.8% (P ϭ 0.07) vs. nonstrain. When ALDS was applied after CSDS, myotube area decreased by 8.8% compared with CSDS only; when applied singularly to fibroblasts, ALDS decreased myotube area by 15.8% vs. nonstrain (P Ͼ 0.05), suggesting that specific strain paradigms applied to fibroblasts regulate myotube hypertrophy. To determine whether myotube contraction was a function of surface area, myotubes from nonstrain coculture were bracketed into Ͻ2,500-, 2,500-to 5,000-, 5,000-to 7,500-, 7,500-to 10,000-, and Ͼ10,000-m 2 areas, and sigmoid-shaped doseresponse curves were analyzed. We found that Hill slope coefficients were greatest for small-area (Ͻ5,000-m 2 ) myotubes. However, there were no significant differences in ED 50 values among myotube areas (2.1-6 nM, data not shown). Thus we concluded that fibroblast-induced myotube hypertrophy did not account for the contractile responses induced by ACh among coculture treatments.
AChR binding is required for in vitro myotube contraction. To show that ACh-AChR binding is a necessary component for the progressive decreases in myotube area measured by our in vitro apparatus, unconjugated ␣-BGT was added to myotubes to block nAChRs. We found that unconjugated ␣-BGT (5 g/ml) incubated in coculture for 1 h was sufficient to block the binding of rhodamine-conjugated ␣-BGT without detectable cytotoxic effects (data not shown). ␣-BGT-treated myotubes were then immediately perfused with ACh (10 Ϫ11 -10 Ϫ3 M). No concentration of ACh could decrease fractional shortening of myotubes Ͼ95% of their original resting length (Fig.  3B) . To show that ␣-BGT-treated myotubes were contractile independent of nAChRs, we administered a final dose of KCl (10 Ϫ2 M), which induced area shortening greater than precontraction (P Ͻ 0.05).
Our PBS-based perfusate (catalog no. P3813, Sigma) did not contain Ca 2ϩ , and many adhesion molecules are Ca 2ϩ -dependent. To test whether Ca 2ϩ -dependent adhesion affected fractional shortening, 1.8 mM Ca 2ϩ was added to the perfusate, and ACh (10 Ϫ11 -10 Ϫ3 M) was administered to myotubes differentiated in the presence of nonstrained fibroblasts. Ca 2ϩ -containing perfusate had no effect on the log(ACh) ED 50 -free perfusate by 78.5 Ϯ 4.3% and 68.7 Ϯ 3.8, respectively (P Ͻ 0.05; Fig. 3B ). PBS only was also used to verify that the superficial velocity of the perfusate was not shearing myotubes from the coverslips. PBS only was not capable of inducing loss of cell adhesion (data not shown).
Together, these data show that our in vitro contraction model decreases the original resting length of myotubes within the range of sarcomere-dependent shortening (42) . Of the parameters tested, Ca 2ϩ in the ACh medium blocked 31% of cell contraction (between 32% shortening in Ca 2ϩ -free medium and 22% shortening in 1.8 mM Ca 2ϩ ), suggesting that adhesion molecules in myotube cultures may attest to the isometric-like contractions identified in length-shortening experiments ( Fig.  2A) . However, ␣-BGT inhibition of nAChRs prevented 84% of cell contraction and suggests that the major source of fractional shortening in our system is derived from an ACh-nAChRmediated process.
Cyclically strained fibroblasts enhance myotube nAChR expression. As ACh-induced contractions are dependent on ligand binding to its receptor, expression of nAChRs from cocultured myotubes was measured (Fig. 5 ). Nonstrained and ALDS-treated fibroblasts did not significantly alter protein expression vs. uniculture (1.50 Ϯ 0.37 and 1.57 Ϯ 0.51 fold, respectively). However, CSDS-treated fibroblasts increased AChR expression vs. uniculture (2.36 Ϯ 0.43 fold, P Ͻ 0.05), and CSDS ϩ ALDS-treated fibroblasts followed a similar trend (2.46 Ϯ 0.79 fold, P ϭ 0.10). Expression among coculture groups was not significantly different. We also measured nAChR expression from agrin-treated and untreated myotubes grown in DM. Both groups expressed nAChR but were not significantly different from one another (data not shown).
Cyclically strained fibroblasts disrupt AChR cluster formation on myotubes. Agrin induces AChR clustering (23) . Therefore, agrin-treated myotubes were used to demonstrate that AChR clusters could be appropriately produced and identified using our model. Figure 6 shows that agrin-treated myotubes increased ␣-BGT-labeled cluster area (m 2 ) per myotube by fivefold vs. untreated myotubes (1,900 Ϯ 200 vs. 300 Ϯ 100, P Ͻ 0.05). The same analysis criteria were used to identify and measure AChR clusters in all coculture groups. Nonstrained fibroblasts increased AChR clusters vs. uniculture by twofold (928 Ϯ 175 vs. 438 Ϯ 141, P Ͻ 0.05), and ALDS-treated fibroblasts further increased clusters by threefold (1,478 Ϯ 190) . However, CSDS-and CSDS ϩ ALDStreated fibroblasts reduced ␣-BGT-stained cluster area by 300 and 350 m 2 per myotube, respectively, vs. nonstrained fibroblasts. nAChR cluster areas were further reduced compared with ALDS-treated fibroblasts (P Ͻ 0.05) and were not statistically different from uniculture myotubes (P ϭ 0.3).
To further characterize the unique AChR clustering patterns produced by strain-activated fibroblasts, a histogram was created to quantify the distribution of AChR cluster size and number on each myotube (Fig. 7, B-H) . A total of 2,045 clusters from 574 myotubes were identified and analyzed. Histogram analyses confirmed that fibroblasts increased myotube ␣-BGT-stained cluster area as a function of number and size (Fig. 7I) . ALDS-treated fibroblasts increased cluster frequency vs. uniculture at 4 -8 m 2 and all areas Ն32 m 2 . The central tendency for these clusters was to be larger than those induced by nonstrained fibroblasts (geometric mean, P Ͻ 0.05). Nonstrained fibroblasts followed a trend similar to ALDS-treated fibroblasts at 4 -8 and 32-64 m 2 but failed to reach significance at larger areas vs. uniculture. CSDS-and CSDS ϩ ALDS-treated fibroblasts did not reach significance vs. uniculture. At cluster areas Ͼ512 m 2 , CSDS-and CSDS ϩ ALDS-treated fibroblasts decreased myotube cluster numbers relative to noncyclically strained coculture groups (P Ͻ 0.05). Our positive control, agrin-treated myotubes increased AChR clustering by 4-to 10-fold across all size ranges vs. untreated myotubes, thus validating our staining and identification techniques (see Fig. 9A ).
Cyclically strained fibroblasts increase nonclustered AChR regions on myotubes. nAChR clustering was puzzlingly inconsistent, with Western blot expression data suggesting that exclusive events were causing preexisting receptors to reorganize in clusters. In support of the idea, while investigating colocalization of nAChR clusters and myonuclei, Englander and Rubin (19) found an inverse distribution between nAChR clusters and microaggregates. We predicted that the fluorescence intensity of these microaggregates would fall below the Ն65% threshold defined by agrin-induced clustering, thus accounting for the inconsistency between our clustering and expression data. To show proof of concept that strain-activated fibroblasts were capable of reorganizing nAChRs in this context, nonclustered regions were quantified.
Nonclustered AChRs were defined as the ␣-BGT-stained area occupied on myotubes with Ͻ65% intensity (Fig. 8, A-C) . The majority (82-94%) of ␣-BGT staining was contained within these nonclustered domains for all treatments. CSDSand CSDS ϩ ALDS-treated fibroblasts increased the area occupied by nonclustered AChRs by 3,300 and 4,800 m 2 per myotube vs. uniculture ( Fig. 8D ; P Ͻ 0.05). While nonstrained and ALDS-treated fibroblasts also increased nonclustered AChRs by 2,600 and 2,000 m 2 , respectively, vs. uniculture, these data were not significant (P ϭ 0.06 and 0.16). The positive control, agrin-treated myotubes did not affect the area occupied by nonclustered AChRs vs. untreated myotubes (7,900 Ϯ 25 vs. 9,100 Ϯ 1,000).
Myotube contractile sensitivity correlates with increased nAChR expression but not AChR clustering. The contraction ED 50 value for each coculture treatment was plotted against AChR expression, AChR clusters, and nonclustered AChR regions, and linear regression analyses were calculated (Fig. 9 , 50 and AChR expression correlated in a manner suggesting that increased nAChR expression results in increased ACh-induced contractile sensitivity (R 2 ϭ 0.84). Contractile sensitivity and AChR expression did not correlate with AChR clustering (R 2 ϭ 0.00 and 0.02). However, both correlated with area occupied by nonclustered AChRs (R 2 ϭ 0.71 and 0.87, respectively). There was an inverse correlation between clustered and nonclustered AChRs for cocultured myotubes (Fig. 9, D-F) .
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DISCUSSION
Muscle damage occurs in response to injury, inflammation, and chronic disease. Utilization of cellular strategies that target endogenous cells within the body to improve muscle repair and function is timely, as we are entering an era where it is possible to evaluate the integrated effects of several cell types (3). We previously showed that fibroblasts, which exist in tissues juxtaposed to skeletal muscle, are activated through mechanical strain to secrete cytokines, such as IL-6, to enhance myoblast differentiation (27) . We confirmed that fibroblasts, and not fluid forces, induce myoblast differentiation, and no cytotoxic effect was measured in coculture. This study also shows that fibroblasts markedly affect myotube functionality and, when activated by mechanical strain forces, further modify the myotube phenotype.
Our data show that myotubes respond to ACh by shortening in length and decreasing in area. Low doses of ACh induce myotubes to shorten and return to original resting position, providing evidence for in vitro contraction. In response to larger doses of ACh, myotubes reached a threshold at which contraction resulted in loss of cell adhesion and did not return to original resting position following PBS wash. Importantly, we show that increased doses of ACh result in cumulative loss of cell adhesion consistently measurable across all treatment groups.
Our in vitro contraction model highlights the fact that fibroblasts promote the differentiation of highly contractile myotubes. In no instance did strained or nonstrained fibroblasts desensitize ACh-induced myotube contraction. However, our experimentally derived Hill coefficients (Fig. 3B ) are less cooperative than pharmacologically derived ACh-AChR binding Hill coefficients of 1.2-1.6 (50) . One possible explanation is that low doses of ACh induce isometric-like contractions, where intracellular tensions cause structural shortening but do not change myotube surface area measurements. Thus our coefficient values may in part be derived from competition between myotube attachments that delay the progressive decrease in cell area. However, extracellular matrix and surface attachments formed by myotube proteins or soluble proteins secreted from the fibroblasts were not measured. Fibroblasts also secrete proteases, such as matrix metalloproteinases, which could modify myotube attachments and impact their contractile response. Of the parameters we tested, nAChRs were found to be necessary for contraction (Fig. 3B) . Thus cofactors of the nAChR complex, such as MuSK, are also likely to contribute to contraction in our in vitro model.
Our results of fibroblast-stimulated myotube contraction complement the research of Cooper et al. (13) showing that C2C12 myotubes grown on a fibroblast-feeder layer prolonged viability and produced functionally mature myofilaments. Cooper et al. partially attributed the myotube functional maturity to the secretion of extracellular matrix components and growth factors derived from the fibroblasts. We support the idea that fibroblasts secrete mediators that affect myotube contraction, as cells in our coculture were spatially separated and could only interact through paracrine mechanisms. We also showed that strain-activated fibroblasts regulate myotube contractile sensitivity and support nAChR signaling as a potential mechanism.
We found that cyclically strained fibroblasts increase myotube nAChR expression, which correlated to ED 50 sensitivity (Fig. 9A) . The increased expression of nAChR may be in response to the unique fibroblast cytokine secretion profile activated by CSDS. Our laboratory previously quantified the secretion of 60 CSDS-derived cytokines that include many candidates of nAChR expression and motor neuron plasticity, such as brain-derived neurotrophic factor (36) . CSDS-treated fibroblasts also upregulate TNF␣ and IFN, which, in turn, upregulate nAChR expression (39). Thus we speculate that strain-activated fibroblasts could secrete cytokines that direct postsynaptic development.
Skeletal muscle nAChRs are continuously internalized and degraded or transcribed and integrated into the sarcolemma. We show that agrin induces nAChR clustering by more than twofold compared with all other treatments, and the presence of fibroblasts also aggregated nAChR clusters (Fig. 7) . While fibroblasts do not appear to express agrin (51), fibroblasts secrete several potent and specific mediators of nAChR clustering, such as neuregulin-1 and brain-derived neurotrophic factor, which are implicated in the regulation of synapse formation and maintenance (10, 38) .
Cyclically strained fibroblasts prevented formation of nAChR clusters. This finding contradicted our initial hypothesis that nAChR expression and clustering would be proportional based on the assumption that more receptors should result in more intense fluorescent staining of random clusters. The finding that the formation of low-pixel-intensity nAChRs paralleled protein expression (Fig. 9C) suggests that nAChRs are initially introduced into the muscle sarcolemma in nonclustered regions and that separate regulatory mechanisms control their aggregation. These data are supported by the finding of Englander and Rubin (19) that nAChRs preferentially exist in microaggregates but, when treated with an extract from Torpedo electric tissue, coalesce in larger clusters. Englander and Rubin measured an inverse distribution between microaggregates and larger clusters, suggesting a dynamic remodeling process of preexisting receptors induced by paracrine mechanisms. In our hands, myotubes differentiated in the presence of strained fibroblasts also formed nAChR clusters that inversely correlated with nonclustered regions (Fig. 9D) , suggesting that secreted mediators from fibroblasts are capable of remodeling nAChR clusters.
Taking into account that nonstrained fibroblasts induce AChR clusters, while CSDS-treated fibroblasts decrease clusters and increase expression, we offer the following possibility. We previously demonstrated that CSDS-treated fibroblasts phenotypically resemble fibroblasts derived from an injury (35) , and secretion of lysosomal and nonlysosomal proteases is commonly upregulated by fibroblasts during injury and periods of prolonged biomechanical stress (2) . Thus it is reasonable that CSDS-treated fibroblasts could disrupt, or prevent, AChR clusters from forming through proteolytic activity. Using antibodies against nAChR to inoculate otherwise healthy animals with a model of experimental autoimmune myasthenia gravis, Guyon et al. (24) demonstrated that degradation of AChR clusters is followed by a compensatory increase in nAChR expression. Guyon et al. found that experimental autoimmune myasthenia gravis is associated with increased TNF␣ and IFN, which we have shown are secreted by CSDS-treated fibroblasts. Thus we speculate that CSDS-mediated disruption of nAChR cluster formation is followed by a CSDS-mediated compensatory upregulation of nAChR expression.
The hypothesis that nAChR cluster aggregation would correlate with increased contractile sensitivity, perhaps through synchronous depolarization, was found to be incorrect. ED 50 values correlated with the expression of nonclustered AChRs. One potential source for consistency in the literature is in the field of muscle denervation, where following the loss of innervation, nAChR clusters disperse across the sarcolemma and protein expression increases (11). Bernareggi et al. (4) found that microtransplantation of sarcolemma into Xenopus oocytes derived from denervated muscle generated ACh currents 50 times stronger than those elicited from innervated muscle. Similarly, our CSDS regimen dispersed clusters, increased nAChR expression, and hypersensitized myotube contraction (Fig. 3) . We suggest that fascia fibroblasts may be one exogenous source for noninvasive treatment options, such as through the targeted stretching of fibroblast-rich tissues, to sensitize nearby muscle contraction. Of clinical relevance, focal dystonias are common risk factors of repetitive strain injuries that are treated with botulinum toxin (BOTOX)-inhibited ACh release to stop hypersensitive muscle contraction (43) . While our coculture does not contain motor neurons, it is tempting to speculate about the roles of strain and fibroblasts in such clinical settings, and we advocate the future use of animal and human models to validate our findings, which could lead to novel therapeutics for motor dysfunction through attenuation of the fibroblast stress response.
Manual therapy techniques that apply long-duration stretch to fibroblast-rich tissues are clinically prescribed to correct somatic dysfunction associated with musculoskeletal injuries (34) to restore muscle function (15, 31) . Therefore, we were keenly interested in applying a modeled manipulative treatment to fibroblasts and measuring functional outcomes in myotubes. We show that ALDS-treated fibroblasts increased nAChR cluster number and size on myotubes (Fig. 7B) . Maintenance of the postsynaptic receptors is critical for preventing axonopathies associated with motor neuron diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy (21), as they send retrograde signals that are necessary for presynaptic differentiation (52). We do not want to overreach on any interpretation for the significance of ALDS-treated fibroblasts in our in vitro setting; however, it is conceivable that just as Schwann cells and motor neurons regulate synapse formation through paracrine processes (20) , fibroblasts, which are highly adaptable to biomechanical strain and juxtaposed to nAChRs during strain-induced muscle contraction, might also contribute to this process. Cellular strategies to improve nAChR clustering and expression, e.g., through engraftment of bioengineered skeletal muscle seeded with strain-activated fibroblasts or through physical therapy regimens targeting fibroblast-rich tissue, may help neuromuscular innervation (30) and improve clinical outcomes associated with neuromuscular disorders.
While many experimental approaches are currently being developed to address the effects of multiple cell types on muscle regeneration (6, 28, 45) , our simple coculture system modeled after a myofascial junction shows proof of concept that fibroblasts are a novel cell type directing all stages of myoblast differentiation, including myotube contractility and nAChR organization. Our coculture has the potential to be expanded to investigate interactions between multiple cell types, such as fibroblast-regulated innervation of skeletal muscles by motor neurons, and strain-activated class switching of fibroblast subpopulations, such as the platelet-derived growth factor receptor-␣ and ADAM12 lineages (18) . We speculate that biomechanical strain serves as one stimulus regulating the phenotypic shift in fibroblasts that leads to pathogenesis or regeneration-favoring milieus for skeletal muscle (22) and provide evidence that cyclically and acyclically strained fibroblasts have profoundly different effects on nearby muscle cells. However, we examined only three strain paradigms, and we recently showed that variations to our ALDS model in strain magnitude and duration elicit many different fibroblast responses (7) . We support the future use and optimization of strain paradigms and our coculture model to further investigate fibroblast responses that could lead to novel therapeutics for improved skeletal muscle regeneration.
